A large language model (LLM) artificial intelligence (AI) system can match, or in some cases outperform, human ophthalmologists in the diagnosis and treatment of patients with glaucoma and retina disease, according to research from New York Eye and Ear Infirmary of Mount Sinai (NYEE).
Genentech gets gluey, paying $47M upfront to Orionis for degrader discovery deal
In its second deal announced Wednesday morning, Roche’s Genentech is signing up with Orionis Biosciences for a molecular glue partnership in cancer and neurodegeneration. Genentech